Evidence Review
Copyright ©The Author(s) 2021.
World J Clin Oncol. Oct 24, 2021; 12(10): 833-844
Published online Oct 24, 2021. doi: 10.5306/wjco.v12.i10.833
Table 2 Proposed predictive model for locoregional recurrence in stage IIIA N2 non-small cell lung cancer[41]
Risk model for LRR in stage pIIIA-N2 NSCLC
Factor
Category
Score
EGFR statusWild- type4
LMRLMR < 4.692
Type of surgeryThoracotomy3
LNRLNR ≥ 38.94
Risk groupScore3-yr LRFS
Low risk0-271.4%
Medium risk3-557.3%
High risk6-1313.6%